US 12421292
Anti-DLL3 chimeric antigen receptors and uses thereof
granted A61KA61K2039/505A61K2239/31
Quick answer
US patent 12421292 (Anti-DLL3 chimeric antigen receptors and uses thereof) held by Legend Biotech Ireland Limited expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Legend Biotech Ireland Limited
- Grant date
- Tue Sep 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K2039/505, A61K2239/31, A61K2239/38, A61K38/00